Emerging links between gut dysbiosis, aryl hydrocarbon receptor activation, and Parkinson's disease.

Gut dysbiosis and altered tryptophan metabolism generate bioactive metabolites that regulate aryl hydrocarbon receptor (AhR) signaling, linking these pathways to Parkinson’s disease (PD) mechanisms.

• Why it matters: PD is a multisystem disorder with early non-motor gastrointestinal disturbances, and the gut-brain axis may help explain sustained systemic and central inflammation.
• What they did: This review examines how tryptophan metabolism via serotonin, kynurenine, and indole pathways produces AhR ligands, and how AhR influences immune balance, glial responses, and barrier integrity.
• The result: The authors propose that altered AhR signaling may connect gut dysbiosis and disrupted tryptophan metabolism to inflammation in PD, supporting relevance to early diagnosis and disease-modifying therapies.